D
Digestiva
Discovering and developing proprietary ingredients to amplify the power of protein nutrition in foods and dietary supplements
About Digestiva
Digestiva is a biotechnology company that focuses on the development of enzyme technology to enhance protein nutrition in foods and dietary supplements. Established in 2006, the company's primary mission is to improve the nutritional value of food products through the application of its specialized enzyme solutions. Digestiva's business model revolves around research and development of these enzymes, which are then likely licensed or sold to food manufacturers and producers of dietary supplements. The company operates in the food technology and biotechnology markets, serving clients who are looking to improve the protein content and digestibility of their products. By enhancing protein nutrition, Digestiva's technology can contribute to better health outcomes for consumers, addressing the growing demand for more nutritious food options.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2018
- Headquarters
- Davis, United States
- Employees
- 17
- Open positions
- None listed
- Dealroom signal
- 72.3/100
- Industry
- Food
- Sub-industry
- Innovative Food
- Sector
- Food, Dietary Supplements, Biotechnology, Nutrition, Spinout
- Technology
- Hardware
- Business model
- Manufacturing
- Client focus
- b2b
Latest news
Press, funding announcements and product moves mentioning Digestiva.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Jul 2024 | $18M | $74M | UC Investments · Astanor Ventures · The March Group | ↗ |
| SPINOUT✓Other financing | Feb 2018 | $0 | — | Icahn School of Medicine at Mount Sinai | — |
Growth signals
Latest recorded traffic for Digestiva is 3.6K monthly website visits, up 125% over the last three months. Digestiva's team grew 30.8% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
UC Investments
Astanor Ventures
The March Group
Other known investors1 additional known investor
Icahn School of Medicine at Mount Sinai
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Digestiva on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Digestiva’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.